Dr. Rafael Meza is PI for CAsToR at the University of Michigan and co-Lead of Projects 1 - 2, as well as the Data Analysis and Dissemination Core. He is an Associate Professor of Epidemiology at the University of Michigan, as well as Co-Lead the Cancer Epidemiology and Prevention Program at the UM Rogel Cancer Center. His research utilizes mathematical modeling to assess risk of and develop screening tools for cancer. Dr. Meza has extensive experience in tobacco simulation modeling and has developed models as Coordinating PI for the Cancer Intervention and Surveillance Modeling Network (CISNET) lung group.
David Levy, PhD
David Levy, PhD
Georgetown University: Professor, Georgetown University Medical Center
Dr. David Levy is PI for CAsToR at Georgetown University and co-Lead of Projects 1 - 3, and the Research Assessment and Input Development Core. He received his PhD in Economics from UCLA (USA), and is currently a Professor of Oncology at Georgetown University. He has published over 250 articles, in renowned journals such as the American Economic Review, BMJ, AJPH, JAMA, The Lancet, Tobacco Control, and PLOS Medicine. He has been principal investigator of grants from the CDC, WHO, the National Cancer Institute, and Bloomberg/Gates Foundation. Dr. Levy currently oversees the design and development of the SimSmoke tobacco policy simulation model, for which he has developed models for over 40 countries covering 85% of the world’s population, and has recently developed models of smokeless tobacco and e-cigarette use. In addition to being a principal investigator on the TCORS grant, he is currently a principal investor on a National Cancer Institute grant with the InternationalTobaccoControl Policy Evaluation Project (theITCProject) in which he has developed models of e-cigarette use for Canada, England and France; and is a principal investigator on the National Cancer Institute CISNET Lung Group. He has recently published articles providing a public health framework for evaluating e-cigarettes and showing the potential benefits of e-cigarettes, as well as papers on the cigarette and e-cigarette markets.